LSTR vs VRTX · P/E 61, rev $4.82B vs P/E 30, rev $12.00B
Landstar System Inc (LSTR) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Landstar System Inc (LSTR) is a integrated freight & logistics company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LSTR revenue for 2024-12-28 was $4.82B. Net income was $195.9M. Revenue was down 9.1% from 2023-12-30 to 2024-12-28. LSTR currently screens at market cap $7.45B and trailing P/E 60.6.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LSTR currently screens at market cap $7.45B and trailing P/E 60.6. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LSTR and VRTX stock pages for the full models.
Not investment advice.